hepat
c
viru
hcv
infect
million
patient
worldwid
one
primari
contributor
liver
diseas
pegyl
interferon
alpha
combin
ribavirin
current
standardofcar
chronic
hcv
infect
progress
diseas
follow
chronic
hcv
infect
differ
among
individu
suggest
host
genet
factor
singlenucleotid
polymorph
snp
affect
cours
chronic
hcv
infect
synthetas
oa
among
first
ifninduc
enzym
identifi
oasrnas
l
system
play
role
innat
immun
respons
viral
infect
sever
studi
identifi
snp
gene
influenc
antivir
effect
ifn
sever
acut
respiratori
syndrom
sar
west
nile
viru
infect
west
nile
viru
hcv
belong
flavivirida
therefor
hypothes
snp
would
affect
cours
chronic
hcv
infect
use
high
resolut
melt
hrm
pcr
analysi
evalu
whether
gene
snp
identifi
popul
liaon
provinc
china
associ
suscept
chronic
hcv
infect
group
hcv
case
healthi
control
examin
three
snp
nonsynonym
ag
snp
sixth
exon
correspond
substitut
ag
snp
spliceacceptor
site
exon
nonsynonym
ag
snp
third
exon
correspond
chronic
hcvinfect
chines
patient
n
men
women
mean
age
year
consult
first
hospit
china
medic
univers
novemb
april
select
studi
elig
patient
test
posit
hcv
antibodi
abbott
laboratori
usa
detect
iuml
serum
hcv
rna
measur
indirectli
realtim
reversetranscriptas
pcr
qiagen
germani
patient
posit
hepat
viral
infect
exclud
studi
studi
approv
institut
ethic
committe
china
medic
univers
procedur
follow
institut
guidelin
healthi
control
n
men
women
mean
age
year
histori
hepat
select
among
physic
examin
case
first
hospit
china
medic
univers
novemb
april
mean
age
gender
ratio
significantli
differ
two
group
p
p
respect
genom
dna
extract
whole
blood
use
qiaamp
dna
micro
kit
qiagen
accord
manufactur
instruct
extract
dna
dissolv
thermo
fisher
scientif
usa
store
hrmpcr
roch
appli
scienc
germani
use
snp
genotyp
sampl
spike
wildtyp
dna
standard
primer
anneal
temperatur
rang
flank
short
bp
sequenc
design
use
primer
tabl
realtim
pcr
cycl
hrm
analysi
conduct
use
light
system
roch
pcr
compon
includ
master
mix
roch
contain
faststart
taq
dna
polymeras
reaction
buffer
dntp
hrm
dye
forward
revers
primer
sangon
biotech
china
nm
roch
wildtyp
mutant
homozygot
distinguish
spike
sampl
known
genotyp
sequenc
pcr
unknown
genom
dna
ng
use
templat
along
addit
ng
ng
known
wildtyp
dna
obtain
sequenc
previous
roch
ad
bring
final
reaction
volum
pcr
conduct
plate
volum
use
follow
touchdown
pcr
cycl
hrm
condit
initi
hold
cycl
touchdown
cycl
decreas
anneal
rang
follow
amplif
sampl
heat
cool
min
encourag
heteroduplex
format
hrm
curv
data
obtain
melt
rang
rate
data
acquisit
per
result
analyz
use
light
gene
scan
softwar
sampl
select
random
verifi
direct
sequenc
sequenc
detect
system
appli
biosystem
usa
data
analyz
use
spss
equilibrium
linkag
disequilibrium
result
haplotyp
examin
use
haploview
genotyp
allel
frequenc
gene
healthi
group
chronic
hcvinfect
group
analyz
use
chisquar
test
relationship
polymorph
risk
hcv
analyz
use
odd
ratio
confid
interv
ci
statist
signific
set
p
hrmpcr
use
genotyp
sampl
gene
spike
wildtyp
dna
standard
fig
genotyp
result
obtain
use
hrm
direct
sequenc
consist
genotyp
allel
frequenc
three
snp
distribut
accord
equilibrium
control
chronic
hcvinfect
group
tabl
control
popul
distribut
frequenc
aa
ag
gg
genotyp
g
allel
respect
genotyp
allel
frequenc
frequenc
respect
term
gene
snp
genotyp
allel
frequenc
chronic
hcvinfect
case
control
observ
higher
frequenc
aa
genotyp
chronic
hcvinfect
patient
control
p
ci
allel
frequenc
allel
significantli
higher
chronic
hcvinfect
patient
control
p
ci
genotyp
allel
frequenc
frequenc
aalleleposit
genotyp
aa
ga
allel
greater
chronic
hcvinfect
group
control
aa
ga
genotyp
p
ci
aallel
p
ci
linkag
disequilibrium
within
diseas
locu
may
stronger
haplotyp
singl
allel
examin
whether
previous
determin
haplotyp
associ
chronic
hcv
infect
linkag
disequilibrium
characterist
sampl
follow
r
linkag
disequilibrium
characterist
follow
r
haplotyp
gga
creat
g
allel
allel
hap
appear
frequent
chronic
hcvinfect
patient
group
control
p
three
haplotyp
frequenc
differ
significantli
two
group
tabl
calcul
versu
three
haplotyp
use
twoway
conting
tabl
analysi
subject
carri
haplotyp
increas
risk
chronic
hcv
infect
ci
oass
famili
ifninduc
enzym
compris
first
ifninduc
enzym
identifi
four
oa
gene
map
chromosom
describ
human
oasl
oaslik
oa
enzym
involv
antivir
effect
ifn
via
oasrnasel
pathway
follow
exposur
novel
virus
ifni
one
first
cytokin
releas
immunecompet
cell
ifni
subsequ
initi
innat
antivir
respons
via
induct
numer
ifnstimul
gene
among
oa
gene
encod
synthesi
oligoadenyl
gener
structur
ppp
na
requir
doublestrand
ds
rna
structur
viral
genom
becom
activ
activ
enzym
catalyz
polymer
atp
oligoadenyl
turn
bind
activ
latent
rnasel
degrad
viral
genet
materi
inhibit
protein
synthesi
among
healthi
control
major
genotyp
aa
minor
allel
tabl
result
consist
report
previous
chen
lubiao
major
genotyp
ag
minor
allel
snp
distribut
report
previous
howev
data
consist
chines
popul
dbsnp
databas
http
wwwncbinlmnihgovprojectssnp
frequenc
distribut
three
site
chines
popul
differ
caucasian
japanes
vietnames
popul
therefor
genotyp
allel
frequenc
snp
vari
race
knapp
report
previous
associ
chronic
hcv
infect
hamano
report
snp
associ
sar
lim
suggest
allel
risk
factor
initi
infect
west
nile
viru
human
fedetz
detect
link
gene
snp
suscept
multipl
sclerosi
howev
relationship
type
diabet
inconsist
observ
associ
chronic
hcv
infect
specif
aa
genotyp
allel
appear
frequent
among
patient
among
healthi
control
snp
correspond
amino
acid
substitut
although
two
snp
complet
linkag
disequilibrium
r
may
function
snp
posit
last
nucleotid
intron
serv
spliceacceptor
site
exon
allel
predict
abrog
splice
site
splice
occur
downstream
result
two
mrna
form
design
associ
lower
oa
enzymat
activ
g
allel
site
predict
allow
splice
give
rise
form
high
enzymat
oa
activ
heterozygot
exhibit
intermedi
oa
activ
form
effici
synthes
degrad
viral
genet
materi
inhibit
protein
synthesi
henc
individu
carri
g
allel
gg
ga
locu
less
like
becom
infect
chronic
hcv
studi
frequenc
aa
ag
genotyp
allel
significantli
higher
chronic
hcvinfect
group
compar
control
individu
aa
ag
genotyp
allel
locu
associ
increas
risk
chronic
hcv
infect
data
support
relationship
snp
hcv
suscept
aa
ag
genotyp
allel
risk
factor
chronic
hcv
infect
explain
correspond
amino
acid
substitut
protein
belong
dsdnabind
protein
famili
character
one
dsrnabind
motif
dsrbm
enzym
activ
follow
bind
dsrbm
dsrna
substitut
nearli
amino
acid
within
consensu
dsrbm
decreas
dsrna
bind
ag
polymorph
exon
correspond
substitut
locat
near
dsrnabind
domain
amino
acid
decreas
dsrna
bind
viral
nucleic
acid
degrad
may
explain
observ
differ
individu
differ
allel
exhibit
differ
suscept
chronic
hcv
infect
three
snp
examin
studi
strong
linkag
disequilibrium
complet
linkag
disequilibrium
four
haplotyp
creat
three
allel
creat
g
allel
allel
frequent
detect
chronic
hcvinfect
patient
control
haplotyp
analysi
may
identifi
relationship
diseaserel
polymorph
effect
linkag
disequilibrium
analysi
singlelocu
analysi
observ
individu
carri
significantli
increas
risk
chronic
hcv
infect
mani
classic
techniqu
snp
genotyp
includ
denatur
highperform
liquid
chromatographi
singlestrand
conform
polymorph
denatur
gradient
gel
electrophoresi
allelespecif
oligonucleotid
pcr
perform
hrmpcr
identifi
snp
new
gener
genescan
technolog
hrmpcr
substanti
improv
genotyp
technolog
term
highthroughput
speed
simplic
costeffect
probefre
design
allow
closedtub
analysi
howev
detect
gene
snp
use
hrmpcr
report
previous
detect
gene
snp
sampl
analyz
direct
sequenc
verif
demonstr
genotyp
result
obtain
reliabl
therefor
hrmpcr
simpl
fast
techniqu
detect
snp
gene
hrmpcr
effici
conveni
lowcost
method
suitabl
clinic
analys
identifi
snp
associ
chronic
hcv
infect
demonstr
polymorph
associ
increas
risk
infect
hcv
snp
identifi
studi
use
hrmpcr
may
appli
genet
protect
factor
chronic
hcv
infect
